✦ LIBER ✦

Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials

✍ Scribed by Henry Krum; John J.V. McMurray; Edward Horton; Teresa Gerlock; Bjoern Holzhauer; Lineke Zuurman; Steven M. Haffner; M. Angelyn Bethel; Rury R. Holman; Robert M. Califf

Book ID: 118076449
Publisher: Hindawi Limited
Year: 2010
Tongue: English
Weight: 126 KB
Volume: 28
Category: Article
ISSN: 1755-5914
DOI: 10.1111/j.1755-5922.2010.00146.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of diabetes and cardiovascula

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

✍ Robert M. Califf; Mitradev Boolell; Steven M. Haffner; M. Angelyn Bethel; John M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Incidence of atrial fibrillation in a po

Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

✍ Latini, Roberto; Staszewsky, Lidia; Sun, Jie-Lena; Bethel, M. Angelyn; Disertori 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 197 KB